PRISM BioLab Co.,LTD
Status: Publicly traded
Direct answer
PRISM BioLab Co.,LTD is publicly traded on JPX under the ticker 206A.T.
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This...
Can you invest in PRISM BioLab Co.,LTD?
Yes. PRISM BioLab Co.,LTD is publicly traded on JPX under the ticker 206A.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PRISM BioLab Co.,LTD
Detailed equity research is provided by MarketSnap.